LUCAS 3 vs. ZOLL AutoPulse: Mechanical CPR on a Moving Rig

Why We Reach for the Machine

The physiology of CPR is unforgiving. Coronary perfusion pressure builds slowly over a run of consistent compressions and collapses the instant you pause. Every hands-off second, every shallow compression from a tired rescuer, every interruption to move the cot, drives no-flow time up and perfusion down. Peter Safar's phased model of resuscitation taught us that circulation is a continuous job, not a series of interruptions.

Humans are bad at this when the floor is moving. In the back of an ambulance doing highway speeds, kneeling over a patient, no one delivers guideline-quality compressions. That is the core argument for mechanical CPR: not that the machine is better than a fresh, well-coached rescuer standing still, but that it never gets tired, never gets thrown by a turn, and frees your hands for the airway, the IV, and the waveform capnography that tells you whether any of it is working.

Two Different Machines

The two devices you'll meet attack the chest in fundamentally different ways.

The Stryker LUCAS 3 is a piston device. A suction cup mounted on a rigid frame drives straight down on the sternum at a fixed rate of 102 compressions per minute, to a depth of around 53 mm, with active decompression on the upstroke. It is mechanically simple, fast to deploy, and the depth and rate are locked to guideline targets.

The ZOLL AutoPulse is a load-distributing band (LDB). Instead of a single point on the sternum, a band around the entire thorax tightens and releases, squeezing the whole chest. The device sizes the patient's chest and resistance on the first cycles, then runs at roughly 80 compressions per minute. The theory is that circumferential compression moves more blood per stroke than a point load.

What the Trials Actually Show

Here is where we have to be intellectually honest with each other. The big randomized trials did not show a survival benefit for mechanical CPR over good manual compressions.

• LINC (LUCAS in Cardiac Arrest), ~2,589 patients, found no significant difference in survival with favorable neurologic outcome at six months despite better flow fractions with the device.
• PARAMEDIC, a large UK trial of the LUCAS, found no benefit, and signaled worse outcomes in the subgroup presenting in VF/VT.
• CIRC, ~4,753 patients on the AutoPulse, showed no significant difference in survival to discharge versus manual CPR.
• A non-inferiority RCT comparing AutoPulse and LUCAS head-to-head found neither device clearly superior on safety endpoints.

So why do we still carry them? Because the trials randomized routine arrests, and the device's real value is situational: prolonged codes, transport to the cath lab or ECMO, CPR in a moving vehicle, and crews too small to rotate compressors. The machine doesn't beat a fresh rescuer standing still, it beats the degraded reality of a long transport with two people on the truck.

Choreography Still Wins

A mechanical device is a tool, not a strategy. Drop it on a chaotic code with no pit-crew choreography and you'll add interruptions, not remove them. The discipline is the same as high-performance manual CPR: minimize the pause to deploy it (under ten seconds, practiced relentlessly), confirm correct pad and piston placement, and keep your eyes on the EtCO2 trace.

That capnography number is your scoreboard. A device delivering textbook mechanics with an EtCO2 stuck at 8 mmHg is telling you something the trials can't, that this particular chest isn't perfusing. Use the machine to buy your hands for everything else, and let the waveform tell you whether to keep going.

Sources

• Stryker — LUCAS 3 chest compression system data sheet
• European Heart Journal — AutoPulse vs LUCAS non-inferiority RCT
• PMC — LINC study protocol and rationale
• WestJEM — Mechanical vs manual CPR systematic review and meta-analysis
• ZOLL — AutoPulse technology overview